| 11/18/2005 | CV | Market Commentary: Sonic, CompuCredit edge higher; Doral Financial surges amid rumors; Protein Design gains
|
| 11/1/2005 | CV | Market Commentary: Qwest, Chesapeake Energy to price $2 billion-plus in convertibles; new IPC paper trades actively
|
| 8/3/2005 | CV | Market Commentary: Human Genome to price $230 million of convertibles; Reebok paper jumps on buyout news
|
| 3/14/2005 | CV | Market Commentary: JetBlue a laggard as airline paper up; Delta bankruptcy fears weigh; PDLI gains; Aquila up; Xoma off
|
| 2/16/2005 | CV | Market Commentary: Sybase issue climbs out of gate; BlackRock ends in gray market with no bid; Allied Waste slips
|
| 2/10/2005 | CV | Market Commentary: Guitar holders like acquisition; Coltec up; Protein Design seen re-priced, trades light at 98
|
| 2/9/2005 | CV | Market Commentary: Protein Design Labs sweetened, sinks; Huntsman hotly pursued; Allergan, Sepracor off, Saks up
|
| 2/9/2005 | CV | New Issue: Protein Design Labs sells $250 million of convertibles to yield 2.0%, up 30%
|
| 2/8/2005 | CV | Market Commentary: Southern Union advances, prices tight; Protein Design Labs seen rich; Level 3, EDS dive on results
|
| 2/7/2005 | CV | Protein Design Labs $250 million convertible talked at 1.25%-1.75% coupon, up 30%-35%
|
| 2/7/2005 | CV | Market Commentary: Southern Union, Protein Design launch; Pinnacle Airlines edges up, raises Northwest paper
|
| 8/16/2004 | CV | Market Commentary: LifePoint, Province up on merger, lift takeover risk; American Tower deal seen repriced; Aquila emerges
|
| 7/9/2004 | CV | Market Commentary: Nextel converts gain as stock sold short; Arch Coal buried by warning, Massey down, too
|
| 5/19/2004 | CV | Market Commentary: Calpine up after big drop last week; Kroll bonds flag while stock soars on merger news
|
| 5/17/2004 | CV | Market Commentary: Protein Design Labs plunges, Millennium set to rise on drug results; Thoratec, Tower deals emerge
|
| 9/29/2003 | CV | Protein Design Labs to redeem 51/2% convertibles
|
| 7/10/2003 | CV | S&P rates new Protein Design Labs convert CCC
|
| 7/9/2003 | CV | New Issue: Protein Design Labs sells $250 million convertible to yield 2.75%, up 33%
|
| 7/9/2003 | CV | Market Commentary: CMS deal revived with wider yield talk, joining TXU after close as power issues heat up
|
| 7/8/2003 | CV | Protein Design Labs $250 million convertibles yield 2.75%, up 33%
|
| 7/8/2003 | CV | Market Commentary: Traders note more summer-like flow; some profit taking seen as new deal party rocks on
|
| 7/7/2003 | CV | Protein Design Labs $200 million convertibles talked to yield 2.75-3.25%, up 30-35%
|
| 7/7/2003 | CV | Market Commentary: HealthSouth converts bid up some 20 points on financials; trading sees post-holiday lull
|
| 12/10/2002 | CV | Fitch rates Baxter mandatory A
|
| 7/10/2002 | CV | Market Commentary: Stock plunge, earnings worries sideline players, pressure prices
|
| 5/9/2002 | CV | Wachovia analyst sees PDLI convert as interesting high yield play
|
| 4/10/2002 | CV | Market Commentary: Duane Reade brings new deal in new structure; Biotechs, drugs higher on short covering
|
| 3/26/2002 | CV | Salomon analyst likes PDLI
|
| 3/21/2002 | CV | Convertibles gain as buyers emerge, PDLI clips slide
|
| 3/20/2002 | CV | Market Commentary: Convertibles drop; PDLI joins ViroPharma, other biotechs in freefall
|
| 2/28/2002 | CV | Market Commentary: Convertibles choppy, lower but GM deal upped to $3.25 billion
|
| 12/7/2001 | CV | Market Commentary: Convertible market slides as stock enthusiasm withers, no new deals
|
